Pharmaceutical
| Thu 18 Jun 2026
Beijing, June 18 -- Genentech and Pfizer have filed a patent application for Anti-tl1a Antibody Therapy Methods. This invention was developed by Banfield Christopher R, Chandra Divya E, Hassan-zahra Mohammad, Hu Xiaoyan, Hyde Christopher L, Neelakantan Sreekanth, Piffa Eberhard, Vincent Michael S, Wu Yan, Ye Zhong, Pengoda Sande..